Showing results (371-380 of 575) with videos related to
Sort By:
Pageof 58
BMJ Open|June 16, 2022
Mixed methods evaluation of the Getting it Right First Time programme in elective orthopaedic surgery in England: an analysis from the National Joint Registry and Hospital Episode StatisticsHelen Barratt, Andrew Hutchings, Elena Pizzo, et al.Zootaxa|June 29, 2021
Discovering and documenting Acari: the first twenty years in ZootaxaZhi-Qiang Zhang, Heinrich Schatz, Tobias Pfingstl, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 30, 2007
Analysis of TaALMT1 traces the transmission of aluminum resistance in cultivated common wheat (Triticum aestivum L.)Harsh Raman, Peter R Ryan, Rosy Raman, et al.Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|September 9, 2016
Prevalence, goals of care and long-term outcomes of patients with life-limiting illness referred to a tertiary ICUNeil R Orford, Sharyn L Milnes, Nigel Lambert, et al.Frontiers in Medicine|August 4, 2023
The feasibility, acceptability, and usability of telehealth visitsNaina Sinha Gregory, Alpana P Shukla, Jahi J Noel, et al.Journal of Palliative Medicine|March 22, 2012
Intensive communication skills teaching for specialist training in palliative medicine: development and evaluation of an experiential workshopJosephine M Clayton, Jonathan L Adler, Anne O'Callaghan, et al.Theranostics|February 16, 2026
Modeling immunotherapies in live 3D human cancer tissue bioreactorsYizheng Zhang, Ivan Foth, Ahmad Makky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2020
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort StudyGagandeep Brar, Laura C Pinheiro, Michael Shusterman, et al.Clinical Lymphoma, Myeloma & Leukemia|May 1, 2024
Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin LymphomaMatthew Mei, Ni-Chun Tsai, Joycelynne Palmer, et al.Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategiesRebecca L Elstrom, Peter Martin, Katya Ostrow, et al.Pageof 58